SCHEMBL25974598

SCHEMBL25974598

OBc1ccccc1Oc1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CACNA1B Q00975 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ LTA4H P09960 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ KIF11 P52732 2/20 0.37
▸ BACE1 P56817 1/20 0.36
▸ LIPE Q05469 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ PPARG P37231 1/20 0.36
▸ PPARA Q07869 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28638978 0.82 L3MBTL1 (0.52) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL13753946 0.80 LTA4H (0.46) L3MBTL1ALDH1A1SLC6A4TSHRKMT2A
SCHEMBL5375024 0.77 AR (0.54) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL25974635 0.77 SLC6A4 (0.37) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL9589622 0.76 AR (0.52) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL14677727 0.75 LTA4H (0.52) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL9589613 0.75 AR (0.51) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL25340059 0.74 L3MBTL1 (0.41) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL21858140 0.74 SLC6A4 (0.47) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1
SCHEMBL3748483 0.74 L3MBTL1 (0.41) MAPK14L3MBTL1RAB9ACACNA1BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback